Yes, we certainly do. We're very much involved in collaboration with our international regulatory partners. At the time of a request for authorization, we consider whether a product has been approved in another jurisdiction, particularly with our partners in the United States Food and Drug Administration and the European Medicines Agency. We can get copies of any of their review reports and use them in our own decision-making.
We also participate in teleconferences with those two agencies almost on a monthly basis to discuss certain products that are in the approval process in all three, so that we share information during our review process as well.